Email Page Print Page

SEC Filings and Financial Information

NASDAQBDSI
FormDescriptionDateFormat
10-QQuarterly report which provides a continuing view of a company's financial positionAug 9, 2017View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
10-QQuarterly report which provides a continuing view of a company's financial positionMay 15, 2017View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
NT 10-QNotification that form type 10-Q will be submitted lateMay 10, 2017View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionNov 9, 2016View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
Top News
Oct 12, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that it has entered into a...

Oct 6, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) participated in a round table meeting convened this week in Washington, D.C. by the U.S. Department of Health and Human Services (HHS) to...

Sep 19, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, Vice Chairman, President and Chief Executive Officer, will present at two upcoming healthcare conferences....

investor inquiries

 

Al Medwar
Senior Vice President, Corporate and Business Development
BioDelivery Sciences International, Inc.
919-582-9050
amedwar@bdsi.com